Market News & Trends
CANbridge Acquires License for Apogenix’s Onco-Immunotherapy
CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, has entered into an exclusive license agreement with…
AnaptysBio Secures $40-Million Financing
AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology, recently announced the completion of an oversubscribed $40MM Series…
CiMaas & PharmaCell BV Enter Collaborative Agreement
CiMaas BV, a company developing cellular immunotherapy for cancer, and PharmaCell BV, a leading Contract Manufacturing Organization for Cellular Therapies and Regenerative Medicine in Europe,…
EyeGate Signs Licensing Agreement With Valeant Pharmaceuticals
Eyegate Pharmaceuticals, Inc., a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye, today…
Cleave Biosciences Receives Orphan Designation From FDA
Cleave Biosciences recently announced that its lead drug candidate, CB-5083, has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for…
Celsus Therapeutics Buys Volution Immuno Pharma; Combined Company to be Renamed
Celsus Therapeutics and Volution Immuno Pharmaceuticals SA recently announced that they have entered into a Definitive Exchange Agreement, pursuant to which privately-held Volution Immuno Pharmaceuticals…
Allegro Ophthalmics Announces Positive Topline Results From Phase II Trial
Allegro Ophthalmics, LLC, recently announced that the Phase II clinical trial of Luminate® (ALG-1001) in patients with vitreomacular traction (VMT) or vitreomacular adhesion (VMA) met…
Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumors in Pivotal Study
Genentech, a member of the Roche Group recently announced that in the IMvigor 210 study, the investigational cancer immunotherapy atezolizumab (MPDL3280A; anti-PDL1) shrank tumors (objective…
Lonza to Expand Availability of 3D Cell Culture System
Lonza has announced that it has reached an exclusive agreement with TAP Biosystems, part of the Stedim Biotech Group, to distribute the company’s RAFT™ (Real…
DPT Enhances Flexibility & Efficiencies at San Antonio Facility
DPT Laboratories, a contract development and manufacturing organization (CDMO) specializing in semi-solids and liquids, has implemented a new order execution strategy that will enhance operations…